1. RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
   Dan Ke et al, 2023, Frontiers in Immunology CrossRef
2. Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury
   Xiaolu Sui et al, 2023, Mediators of Inflammation CrossRef
3. Simiao Decoction Alleviates Gouty Arthritis by Modulating Proinflammatory Cytokines and the Gut Ecosystem
   Xiaoying Lin et al, 2020, Frontiers in Pharmacology CrossRef
4. NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update
   Wei Xiong et al, 2021, Frontiers in Immunology CrossRef
5. Role of NLRP3 in the pathogenesis and treatment of gout arthritis
   Ya-ru Liu et al, 2023, Frontiers in Immunology CrossRef
6. Integrating network pharmacology and renal metabonomics to reveal the protective mechanism of resveratrol on gouty nephropathy
   Xiaomin Xu et al, 2024, Biomedical Chromatography CrossRef
7. Effect of Clinical Typing on Serum Urate Targets of Benzbromarone in Chinese Gout Patients: A Prospective Cohort Study
   Xiaomei Xue et al, 2022, Frontiers in Medicine CrossRef
8. Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation
   Naveen Challagundla et al, 2022, Immunologic Research CrossRef
9. Sex differences in body composition and serum metabolome responses to sustained, physical training suggest enhanced fat oxidation in women compared with men
   Meaghan E. Beckner et al, 2023, Physiological Genomics CrossRef
10. Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
    Guozheng Li et al, 2020, Frontiers in Pharmacology CrossRef
11. A pilot exploration of multi-omics research of gut microbiome in major depressive disorders
    Haoyang Zhao et al, 2022, Translational Psychiatry CrossRef